Literature DB >> 8617738

Regulation of epithelial sodium channels by the cystic fibrosis transmembrane conductance regulator.

I I Ismailov1, M S Awayda, B Jovov, B K Berdiev, C M Fuller, J R Dedman, M Kaetzel, D J Benos.   

Abstract

Cystic fibrosis airway epithelia exhibit enhanced Na+ reabsorption in parallel with diminished Cl- secretion. We tested the hypothesis that the cystic fibrosis transmembrane conductance regulator (CFTR) directly affects epithelial Na+ channel activity by co-incorporating into planar lipid bilayers immunopurified bovine tracheal CFTR and either heterologously expressed rat epithelial Na+ channel ( alpha,b eta,gamma-rENaC) or an immunopurified bovine renal Na+ channel protein complex. The single channel open probability (Po) of rENaC was decreased by 24% in the presence of CFTR. Protein kinase A (PKA) plus ATP activated CFTR, but did not have any effect on rENaC. CFTR also decreased the extent of elevation of the renal Na+ channel Po following PKA-mediated phosphorylation. Moreover, the presence of CFTR prohibited the inward rectification of the gating of this renal Na+ channel normally induced by PKA-mediated phosphorylation, thus down-regulating inward Na+ current. This interaction between CFTR and Na+ channels occurs independently of whether or not wild-type CFTR is conducting anions. However, the nonconductive CFTR mutant, G551D CFTR, cannot substitute for the wild-type molecule. Our results indicate that CFTR can directly down-regulate single Na+ channel activity, thus accounting, at least in part, for the observed differences in Na+ transport between normal and cystic fibrosis-affected airway epithelia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8617738     DOI: 10.1074/jbc.271.9.4725

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

Review 1.  Novel pharmacologic therapies for cystic fibrosis.

Authors:  P L Zeitlin
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

2.  Pharmacogenomics of the cystic fibrosis transmembrane conductance regulator (CFTR) and the cystic fibrosis drug CPX using genome microarray analysis.

Authors:  M Srivastava; O Eidelman; H B Pollard
Journal:  Mol Med       Date:  1999-11       Impact factor: 6.354

3.  Mechanosensitivity of an epithelial Na+ channel in planar lipid bilayers: release from Ca2+ block.

Authors:  I I Ismailov; B K Berdiev; V G Shlyonsky; D J Benos
Journal:  Biophys J       Date:  1997-03       Impact factor: 4.033

4.  The role of CFTR in transepithelial liquid transport in pig alveolar epithelia.

Authors:  James F Collawn; Sadis Matalon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-07-13       Impact factor: 5.464

5.  Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice.

Authors:  Mathilde Beka; Teresinha Leal
Journal:  J Vis Exp       Date:  2018-07-04       Impact factor: 1.355

Review 6.  The role of inflammation in the pathophysiology of CF lung disease.

Authors:  James F Chmiel; Melvin Berger; Michael W Konstan
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

7.  The cystic fibrosis transmembrane conductance regulator (CFTR) inhibits ENaC through an increase in the intracellular Cl- concentration.

Authors:  J König; R Schreiber; T Voelcker; M Mall; K Kunzelmann
Journal:  EMBO Rep       Date:  2001-10-17       Impact factor: 8.807

8.  Molecular and functional characterization of the cystic fibrosis transmembrane conductance regulator from the Australian common brushtail possum, Trichosurus vulpecula.

Authors:  K J Demmers; D Carter; S Fan; P Mao; N J Maqbool; B J McLeod; R Bartolo; A G Butt
Journal:  J Comp Physiol B       Date:  2009-12-12       Impact factor: 2.200

Review 9.  Barriers to inhaled gene therapy of obstructive lung diseases: A review.

Authors:  Namho Kim; Gregg A Duncan; Justin Hanes; Jung Soo Suk
Journal:  J Control Release       Date:  2016-05-16       Impact factor: 9.776

10.  Preliminary evidence for cell membrane amelioration in children with cystic fibrosis by 5-MTHF and vitamin B12 supplementation: a single arm trial.

Authors:  Cinzia Scambi; Lucia De Franceschi; Patrizia Guarini; Fabio Poli; Angela Siciliano; Patrizia Pattini; Andrea Biondani; Valentina La Verde; Oscar Bortolami; Francesco Turrini; Franco Carta; Ciro D'Orazio; Baroukh M Assael; Giovanni Faccini; Lisa M Bambara
Journal:  PLoS One       Date:  2009-03-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.